Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TP53 DNA binding domain mutational status and rituximab-based treatment are independent prognostic factors for pediatric Burkitt lymphoma patients stratification.
Martire G, Lovisa F, Carraro E, Rizzato D, Cesaro S, Mura RM, Tondo A, Bertolin C, Boaretto F, Salviati L, Biffi A, Pillon M, Mussolin L. Martire G, et al. Among authors: lovisa f. Haematologica. 2024 Feb 22. doi: 10.3324/haematol.2023.284868. Online ahead of print. Haematologica. 2024. PMID: 38385281 Free article.
Quantitative assessment of minimal residual disease for monitoring of paediatric patients with relapsed/refractory anaplastic large-cell lymphoma treated with brentuximab vedotin: A case series.
Contarini G, Carraro E, Lovisa F, Martire G, Lo Nigro L, Sala A, Pillon M, Mussolin L. Contarini G, et al. Among authors: lovisa f. Br J Haematol. 2024 Jan;204(1):352-355. doi: 10.1111/bjh.19151. Epub 2023 Oct 11. Br J Haematol. 2024. PMID: 37822050 No abstract available.
MiR-146a-5p enrichment in small-extracellular vesicles of relapsed pediatric ALCL patients promotes macrophages infiltration and differentiation.
Garbin A, Contarini G, Damanti CC, Tosato A, Bortoluzzi S, Gaffo E, Pizzi M, Carraro E, Lo Nigro L, Vinti L, Pillon M, Biffi A, Lovisa F, Mussolin L. Garbin A, et al. Among authors: lovisa f. Biochem Pharmacol. 2023 Sep;215:115747. doi: 10.1016/j.bcp.2023.115747. Epub 2023 Aug 15. Biochem Pharmacol. 2023. PMID: 37591448
Plasma small-extracellular vesicles enriched in miR-122-5p promote disease aggressiveness in pediatric anaplastic large-cell lymphoma.
Damanti CC, Ferrone L, Gaffo E, Garbin A, Tosato A, Contarini G, Gallingani I, Angioni R, Molon B, Borile G, Carraro E, Pillon M, Scarmozzino F, Dei Tos AP, Pizzi M, Ciscato F, Rasola A, Biffi A, Bortoluzzi S, Lovisa F, Mussolin L. Damanti CC, et al. Among authors: lovisa f. Cancer Commun (Lond). 2023 May;43(5):630-634. doi: 10.1002/cac2.12415. Epub 2023 Apr 4. Cancer Commun (Lond). 2023. PMID: 37014813 Free PMC article. No abstract available.
Phosphoproteomic Analysis Reveals a Different Proteomic Profile in Pediatric Patients With T-Cell Lymphoblastic Lymphoma or T-Cell Acute Lymphoblastic Leukemia.
Veltri G, Lovisa F, Cortese G, Pillon M, Carraro E, Cesaro S, Provenzi M, Buffardi S, Francescato S, Biffi A, Buldini B, Conter V, Serafin V, Mussolin L. Veltri G, et al. Among authors: lovisa f. Front Oncol. 2022 Jul 8;12:913487. doi: 10.3389/fonc.2022.913487. eCollection 2022. Front Oncol. 2022. PMID: 35875136 Free PMC article.
Quantification of Minimal Disease by Digital PCR in ALK-Positive Anaplastic Large Cell Lymphoma: A Step towards Risk Stratification in International Trials?
Damm-Welk C, Lovisa F, Contarini G, Lüdersen J, Carraro E, Knörr F, Förster J, Zimmermann M, Sala A, Vinti L, Tondo A, Pillon M, Woessmann W, Mussolin L. Damm-Welk C, et al. Among authors: lovisa f. Cancers (Basel). 2022 Mar 27;14(7):1703. doi: 10.3390/cancers14071703. Cancers (Basel). 2022. PMID: 35406475 Free PMC article.
Prognostic Role of Minimal Disseminated Disease and NOTCH1/FBXW7 Mutational Status in Children with Lymphoblastic Lymphoma: The AIEOP Experience.
Lovisa F, Gallingani I, Varotto E, Pasin C, Carraro E, Michielotto B, Garbin A, Damanti CC, Pizzi M, d'Amore ESG, Piglione M, Muggeo P, Buffardi S, Vinti L, Folsi VM, Onofrillo D, Biffi A, Buldini B, Pillon M, Mussolin L. Lovisa F, et al. Diagnostics (Basel). 2021 Sep 1;11(9):1594. doi: 10.3390/diagnostics11091594. Diagnostics (Basel). 2021. PMID: 34573936 Free PMC article.
Synergistic Drug Combinations Prevent Resistance in ALK+ Anaplastic Large Cell Lymphoma.
Arosio G, Sharma GG, Villa M, Mauri M, Crespiatico I, Fontana D, Manfroni C, Mastini C, Zappa M, Magistroni V, Ceccon M, Redaelli S, Massimino L, Garbin A, Lovisa F, Mussolin L, Piazza R, Gambacorti-Passerini C, Mologni L. Arosio G, et al. Among authors: lovisa f. Cancers (Basel). 2021 Sep 1;13(17):4422. doi: 10.3390/cancers13174422. Cancers (Basel). 2021. PMID: 34503232 Free PMC article.
Ruxolitinib as a Novel Therapeutic Option for Poor Prognosis T-LBL Pediatric Patients.
Veltri G, Silvestri C, Gallingani I, Sandei M, Vencato S, Lovisa F, Cortese G, Pillon M, Carraro E, Bresolin S, Biffi A, Basso G, Accordi B, Mussolin L, Serafin V. Veltri G, et al. Among authors: lovisa f. Cancers (Basel). 2021 Jul 24;13(15):3724. doi: 10.3390/cancers13153724. Cancers (Basel). 2021. PMID: 34359628 Free PMC article.
30 results